Picard Medical (PMI), parent company of SynCardia Systems, announced that Dr. Andre Simon, Vice President of Clinical Affairs, will deliver three scientific and educational presentations at the Technology and Heart Failure Therapeutics, THT, 2026 conference to be held in Boston from March 2nd to March 4th 2026. Dr. Simon’s presentations will focus on both the current SynCardia Total Artificial Heart, STAH, and the Company’s next-generation fully implantable Emperor system, reinforcing Picard Medical’s leadership in advanced mechanical circulatory support.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PMI:
- Picard Medical Highlights SynCardia Training at THS 2026
- Picard Medical, SynCardia to participate in ‘Hands-On Training Day’
- Picard Medical Inc. Investors Face Significant Losses as Lawsuit Alleged Social-Media Stock Promotion Scheme
- Picard Medical to host ‘SynCardia Total Artificial Heart Training Village’
- Picard Medical Facing Investor Suit Over Alleged Stock Promotion Scheme